The World Health Organization's decision to recommend against using remdesivir to treat COVID-19 patients was based on an inconclusive study, according to an editorial published Dec. 2 in The New England Journal of Medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,